Status:
TERMINATED
A Study to Examine Changes in GIP Plasma Levels Following Gastric Bypass Surgery in Obese Patients
Lead Sponsor:
Boston Medical Center
Conditions:
Obesity
Type 2 Diabetes Mellitus
Eligibility:
All Genders
21-64 years
Brief Summary
Obesity is a multinational epidemic. There is evidence that despite educational measures and increased public awareness, the number of obese individuals continues to increase. Of the numerous obesity-...
Detailed Description
This is a pilot study to collect the relevant information for planning a larger and more definitive investigation. A total of thirty subjects will be evaluated in this study to be conducted at the Bos...
Eligibility Criteria
Inclusion
- Patients 21-64 years of age
- Obese (defined as a body mass index, BMI, \> or = 30)
- Type 2 diabetes or impaired glucose tolerance
- Have been selected and scheduled for gastric bypass surgery.
Exclusion
- Substance abuse
- Consumption of more than two alcoholic drinks per day
- Use of more than 20 units of insulin (any brand or type) per day
- Fasting blood glucose \>180mg/dl on screening bloodwork.
Key Trial Info
Start Date :
March 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00207389
Start Date
March 1 2004
End Date
August 1 2006
Last Update
January 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Boston University Medical Center
Boston, Massachusetts, United States, 02118